We are live on ! Find out more
CAM

Cypress Asset Management Portfolio holdings

AUM $455M
1-Year Est. Return 26.87%
This Fund
S&P 500
This Quarter Est. Return
+25.87%
1 Year Est. Return
+26.87%
3 Year Est. Return
+113.59%
5 Year Est. Return
+132.49%
10 Year Est. Return
+426.19%
AUM
$300M
AUM Growth
+$68.4M
Cap. Flow
+$14.8M
Cap. Flow %
4.93%
Top 10 Hldgs %
30.62%
Holding
131
New
15
Increased
45
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$3.02M
2
PG icon
Procter & Gamble
PG
+$2.55M
3
SBUX icon
Starbucks
SBUX
+$1.5M
4
CL icon
Colgate-Palmolive
CL
+$1.46M
5
SNY icon
Sanofi
SNY
+$1.33M

Sector Composition

Rank Sector Weight
1 Technology 22.58%
2 Healthcare 16.18%
3 Financials 13.25%
4 Consumer Discretionary 13.24%
5 Consumer Staples 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
51
Salesforce
CRM
$153B
$2.03M 0.68%
10,830
-170
-2% -$28.6K
IHI icon
52
iShares US Medical Devices ETF
IHI
$3.36B
$1.97M 0.66%
44,730
+1,890
+4% +$80.8K
BMY icon
53
Bristol-Myers Squibb
BMY
$133B
$1.95M 0.65%
33,237
+4,057
+14% +$243K
WDAY icon
54
Workday
WDAY
$41B
$1.89M 0.63%
10,074
-240
-2% -$38.8K
MCD icon
55
McDonald's
MCD
$191B
$1.82M 0.61%
9,855
-315
-3% -$57.8K
CVS icon
56
CVS Health
CVS
$134B
$1.81M 0.6%
27,897
+2,856
+11% +$180K
PFE icon
57
Pfizer
PFE
$143B
$1.79M 0.6%
57,626
+442
+0.8% +$15K
BLK icon
58
Blackrock
BLK
$174B
$1.73M 0.57%
3,170
-100
-3% -$50.5K
MMM icon
59
3M
MMM
$91.2B
$1.69M 0.56%
12,991
+3,684
+40% +$464K
YUM icon
60
Yum! Brands
YUM
$40.8B
$1.63M 0.54%
18,760
-185
-1% -$15.8K
KO icon
61
Coca-Cola
KO
$374B
$1.48M 0.49%
33,220
-300
-0.9% -$13.8K
SBUX icon
62
Starbucks
SBUX
$119B
$1.47M 0.49%
+20,025
New +$1.5M
TXN icon
63
Texas Instruments
TXN
$245B
$1.43M 0.48%
11,260
-535
-5% -$62.4K
ABBV icon
64
AbbVie
ABBV
$435B
$1.41M 0.47%
14,308
+4,553
+47% +$401K
SNY icon
65
Sanofi
SNY
$103B
$1.4M 0.47%
+27,455
New +$1.33M
AMAT icon
66
Applied Materials
AMAT
$409B
$1.39M 0.46%
22,955
-1,695
-7% -$91.4K
BDX icon
67
Becton Dickinson
BDX
$46.7B
$1.39M 0.46%
5,945
+348
+6% +$83.9K
NFLX icon
68
Netflix
NFLX
$302B
$1.38M 0.46%
+30,240
New +$1.29M
TMO icon
69
Thermo Fisher Scientific
TMO
$214B
$1.35M 0.45%
3,740
-20
-0.5% -$6.7K
TDOC icon
70
Teladoc Health
TDOC
$1.2B
$1.34M 0.45%
7,040
+85
+1% +$14.9K
UPS icon
71
United Parcel Service
UPS
$90.7B
$1.29M 0.43%
11,615
+1,452
+14% +$145K
NVS icon
72
Novartis
NVS
$292B
$1.29M 0.43%
14,765
-60
-0.4% -$5.18K
KLAC icon
73
KLA
KLAC
$236B
$1.29M 0.43%
66,270
-4,200
-6% -$71.8K
NEE icon
74
NextEra Energy
NEE
$179B
$1.22M 0.41%
20,280
-976
-5% -$58.4K
TSM icon
75
TSMC
TSM
$2.11T
$1.2M 0.4%
21,105
-700
-3% -$36.9K

Similar funds

Cypress Asset Management's Q2 2020 Portfolio in Review

As of Q2 2020, Cypress Asset Management held 131 positions worth $300M, up 30% from $232M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cypress Asset Management deployed $14.8M of net new capital in Q2 2020, opening 15 new positions and adding to 45 existing holdings. Its largest new stake was RTX Corp: 48,322 shares worth $2.98M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares US Financial Services ETF, an estimated $1.15M trimmed.

  • Cypress Asset Management's largest Q2 2020 buy was RTX Corp: 48,322 shares worth $2.98M.
  • Cypress Asset Management added most to Procter & Gamble in Q2 2020, an estimated $2.55M increase.
  • Cypress Asset Management's biggest Q2 2020 reduction was iShares US Financial Services ETF, cutting an estimated $1.15M.
  • Cypress Asset Management fully exited Raytheon Company in Q2 2020, selling an estimated $2.73M.
  • Cypress Asset Management's ten largest holdings make up 31% of its $300M portfolio in Q2 2020.
  • Cypress Asset Management opened 15 new positions and closed 2 in Q2 2020.
  • Cypress Asset Management's portfolio value rose 30% quarter-over-quarter to $300M.

Based on Cypress Asset Management's 13F filing for Q2 2020, filed 28 Jul 2020.